KEVIN WILLIAM RAUCHUT
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health WEST HOLLYWOOD, CA NPI 1578084547
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health CA Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$17,506.86
- Category: General Payments
- Program years: PY2021–2024
- Record count: 533
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $8,474.41 across 138 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,237.23 | 126 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,730.00 | 2 |
| Travel and Lodging | $2,504.03 | 7 |
| Education | $3.15 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $5,483.90 | 13 |
| ViiV Healthcare Company | $1,285.56 | 50 |
| Gilead Sciences, Inc. | $382.28 | 13 |
| Bausch Health US, LLC | $146.21 | 10 |
| Lilly USA, LLC | $143.10 | 6 |
| Antares Pharma, Inc. | $125.58 | 6 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $118.40 | 6 |
| ABBVIE INC. | $107.82 | 4 |
| Alkermes, Inc. | $105.20 | 4 |
| EMD Serono, Inc. | $99.19 | 4 |
| Theratechnologies Inc. | $92.78 | 4 |
| Supernus Pharmaceuticals, Inc. | $72.71 | 3 |
| Acerta Pharma LLC | $67.75 | 4 |
| Corium, Inc. | $53.45 | 2 |
| Amgen Inc. | $48.04 | 2 |
| Napo Pharmaceuticals Inc | $40.47 | 2 |
| Janssen Pharmaceuticals, Inc | $32.79 | 1 |
| Almatica Pharma Inc. | $31.16 | 2 |
| ITI, Inc. | $20.48 | 1 |
| GlaxoSmithKline, LLC. | $17.54 | 1 |
By program year
Records — PY2024 (138)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.